2012 IW 1000 Company Profile

Akzo Nobel NV
Pharmaceuticals
Netherlands
2012 IW 1000 Rank:
Current Rank : 217
Prior Rank : 201
Executive 1 : Hans Wijers, Chairman; Chief Executive Officer;
Executive 2 : Keith Nichols, Chief Financial Officer
217 of 1000
Earnings Per Share Growth (%)(37.07%)
Cost of Goods Sold (US$ Millions)$12,508
Current Liabilities (US$ Millions)$6,218
Total Assets (US$ Millions)$8,503
Long Term Debt3926
Return on Equity6.02
Market Capitalization (US$ Millions)$11,335
Price to Earnings Ratio57
Revenue (US$ Millions)$20,312
Total Company Assets$25,700
Revenue Growth (%)7.06%
Net Income (US$ Millions)$700
Earnings Per Share (US$)$2.61
Total Equity (US$ Millions)$11,915
Profit Margin (%)3.44%
Debt To Equity Ratio (%)0.33%
Inventory Turnover2489

Subscribe to IW Newsletters

IW Marketplace - Buy a Link Now